1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Gudiol C, Durà-Miralles X, Aguilar-Company J, Hernández-Jiménez P, Martínez-Cutillas M, Fernandez-Avilés F, Machado M, Vázquez L, Martín-Dávila P, de Castro N, Abdala E, Sorli L, Andermann TM, Márquez-Gómez I, Morales H, Gabilán F, Ayaz CM, Kayaaslan B, Aguilar-Guisado M, Herrera F, Royo-Cebrecos C, Peghin M, González-Rico C, Goikoetxea J, Salgueira C, Silva-Pinto A, Gutiérrez-Gutiérrez B, Cuellar S, Haidar G, Maluquer C, Marin M, Pallarès N, Carratalà J.

    Co-infections and superinfections complicating COVID-19 in cancer patients: a multicenter, international study.

    JOURNAL OF INFECTION . 83(3): 306-313. Nº de citas: 19

    [doi:10.1016/j.jinf.2021.07.014]

  • Lucas A, Chamorro-Tojeiro S, Llenas-García J, Salvador F, Zubero Z, Molina I, Goikoetxea J, López-Vélez R, Pérez-Molina JA.

    Imported leptospirosis in travellers and migrants in Spain: a study of the +REDIVI collaborative network.

    JOURNAL OF TRAVEL MEDICINE . 28(6): . Nº de citas: 1

    [doi:10.1093/jtm/taab095]

  • Lensen KDF, Escudero-Sanchez R, Cobo J, Trebše R, Gubavu C, Tedeschi S, Lomas JM, Arvieux C, Rodriguez-Pardo D, Fantoni M, Pais MJG, Jover F, Salles MJC, Sancho I, Sampedro MF, Soriano A, Wouthuyzen-Bakker M, Escmid Study Group Of Implant Associated Infections Esgiai.

    The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus.

    Journal Of Bone And Joint Infection . 6(7): 313-319. Nº de citas: 3

    [doi:10.5194/jbji-6-313-2021]

  • Shankar-Hari M, Vale CL, Godolphin PJ, Fisher D, Higgins JPT, Spiga F, Savovic J, Tierney J, Baron G, Benbenishty JS, Berry LR, Broman N, Cavalcanti AB, Colman R, De Buyser SL, Derde LPG, Domingo P, Omar SF, Fernandez-Cruz A, Feuth T, Garcia F, Garcia-Vicuna R, Gonzalez-Alvaro I, Gordon AC, Haynes R, Hermine O, Horby PW, Horick NK, Kumar K, Lambrecht BN, Landray MJ, Leal L, Lederer DJ, Lorenzi E, Mariette X, Merchante N, Misnan NA, Mohan SV, Nivens MC, Oksi J, Perez-Molina JA, Pizov R, Porcher R, Postma S, Rajasuriar R, Ramanan AV, Ravaud P, Reid PD, Rutgers A, Sancho-Lopez A, Seto TB, Sivapalasingam S, Soin AS, Staplin N, Stone JH, Strohbehn GW, Sunden-Cullberg J, Torre-Cisneros J, Tsai LW, van Hoogstraten H, van Meerten T, Veiga VC, Westerweel PE, Murthy S, Diaz JV, Marshall JC, Sterne JAC, WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group.

    Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 AMeta-analysis

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION . 326(6): 499-518. Nº de citas: 272

    [doi:10.1001/jama.2021.11330]

  • Grillo S, Cuervo G, Carratala J, San-Juan R, Aguado JM, Morata L, Gomez-Zorrilla S, López-Contreras J, Gasch O, Gomila-Grange A, Iftimie S, Garcia-Pardo G, Calbo E, Boix-Palop L, Oriol I, Jover-Sáenz A, López-Cortés LE, Euba G, Aguirregabiria M, Garcia-Pais MJ, Gioia F, Paño JR, Pedro-Botet ML, Benítez RM, Pérez-Rodríguez MT, Meije Y, Loeches-Yagüe MB, Horna G, Berbel D, Domínguez MÁ, Padullés A, Cobo S, Hereu P, Videla S, Tebe C, Pallarés N, Miro JM, Pujol M.

    Multicentre, randomised, open-label, phase IV-III study to evaluate the efficacy of cloxacillin plus fosfomycin versus cloxacillin alone in adult patients with methicillin-susceptible Staphylococcus aureus bacteraemia: study protocol for the SAFO trial.

    BMJ open . 11(8): . Nº de citas: 2

    [doi:10.1136/bmjopen-2021-051208]

  • Ferrer R, Soriano A, Cantón R, Del Pozo JL, García-Vidal C, Garnacho-Montero J, Larrosa N, Rascado P, Salavert M, Pintado V, Pellicer B, Badía X.

    Revisión sistemática de la literatura y análisis de expertos sobre los factores de riesgo asociados a infecciones causadas por Pseudomonas aeruginosa o Acinetobacter baumannii resistentes a carbapenémicos en pacientes adultos en España.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 34(4): 298-307. Nº de citas: 1

    [doi:10.37201/req/034.2021]

  • Bouza E, Cantón Moreno R, De Lucas Ramos P, García-Botella A, García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, De Pablo Brühlmann S, Porta Etessam J, Santos Sebastián M.

    Síndrome post-COVID: Un documento de reflexión y opinión.

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 34(4): 269-279. Nº de citas: 7

    [doi:10.37201/req/023.2021]

  • Perez-Jacoiste Asin, Maria Asuncion, Bisbal, Otilia, Iribarren, Jose Antonio, Perez-Rivilla, Alfredo, Mican, Rafael, Dronda, Fernando, Gonzalez-Domenech, Carmen Maria, Vinuesa-Garcia, David, Macias, Juan, Lumbreras, Carlos, Moreno, Santiago, Rubio, Rafael.

    Cryptococcal infection in HIV-infected patients with CD4(+) T-cell counts under 100/mu L diagnosed in a high-income country: a multicentre cohort study

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 27(8): . Nº de citas: 1

    [doi:10.1016/j.cmi.2020.09.053]

  • Lazarus JV, Safreed-Harmon K, Kamarulzaman A, Anderson J, Leite RB, Behrens G, Bekker LG, Bhagani S, Brown D, Brown G, Buchbinder S, Caceres C, Cahn PE, Carrieri P, Caswell G, Cooke GS, Monforte AD, Dedes N, Del Amo J, Elliott R, El-Sadr WM, Fuster-Ruiz de Apodaca MJ, Guaraldi G, Hallett T, Harding R, Hellard M, Jaffar S, Kall M, Klein M, Lewin SR, Mayer K, Pérez-Molina JA, Moraa D, Naniche D, Nash D, Noori T, Pozniak A, Rajasuriar R, Reiss P, Rizk N, Rockstroh J, Romero D, Sabin C, Serwadda D, Waters L.

    Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV.

    NATURE COMMUNICATIONS . 12(1): 4450-4450. Nº de citas: 18

    [doi:10.1038/s41467-021-24673-w]

  • Sánchez-Montalvá A, Salinas C, Sullerio E, Salvador F, Bosch-Nicolau P, Crespillo-Andújar C, Trigo E, Roure S, Valerio L, Espinosa-Pereiro J, Molina I.

    Risk of Trypanosoma cruzi infection among travellers visiting friends and relatives to continental Latin America.

    PLOS NEGLECTED TROPICAL DISEASES . 15(7): .

    [doi:10.1371/journal.pntd.0009528]

  • Valencia J, Troya J, Lazarus JV, Cuevas G, Alvaro-Meca A, Torres J, Gardeta C, Lozano D, Moreno S, Ryan P.

    Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain

    Open forum infectious diseases . 8(7): 251-251.

    [doi:10.1093/ofid/ofab251]

  • Salvador F, Lucas-Dato A, Roure S, Arsuaga M, Pérez-Jacoiste A, García-Rodríguez M, Pérez-Molina JA, Buonfrate D, Saugar JM, Molina I.

    Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol

    PATHOGENS . 10(7): . Nº de citas: 2

    [doi:10.3390/pathogens10070812]

  • Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem A, Rehm CA, Agan B, Alvarez-Uria G, Montaner JSG, Lane HC, Larder BA.

    2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.

    The Journal of antimicrobial chemotherapy . 76(7): 1898-1906.

    [doi:10.1093/jac/dkab078]

  • Monge-Maillo B, López-Vélez R.

    Anfotericina B liposomal en el tratamiento de la leishmaniasis visceral.

    REVISTA IBEROAMERICANA DE MICOLOGIA . 38(2): 101-104. Nº de citas: 1

    [doi:10.1016/j.riam.2021.04.002]

  • Pérez-Latorre L, Berenguer J, Micán R, Montero M, Cifuentes C, Puig T, Sanz J, Ferrero OL, De La Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, De Miguel M, Jarrín I, González-García J.

    HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018.

    Eurosurveillance . 26(25): . Nº de citas: 3

    [doi:10.2807/1560-7917.ES.2021.26.25.2000236]

  • Berriatua E, Maia C, Conceição C, Özbel Y, Töz S, Baneth G, Pérez-Cutillas P, Ortuño M, Muñoz C, Jumakanova Z, Pereira A, Rocha R, Monge-Maillo B, Gasimov E, Van der Stede Y, Torres G, Gossner CM.

    Leishmaniases in the European Union and Neighboring Countries.

    EMERGING INFECTIOUS DISEASES . 27(6): 1723-1727. Nº de citas: 16

    [doi:10.3201/eid2706.210239]

  • Cobo J, Escudero-Sanchez R.

    Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective

    ANTIBIOTICS-BASEL . 10(6): . Nº de citas: 3

    [doi:10.3390/antibiotics10060743]

  • Moreno-García E, Puerta-Alcalde P, Gariup G, Fernández-Ruiz M, López Cortés LE, Cuervo G, Salavert M, Merino P, Machado M, Guinea J, García-Rodríguez J, Garnacho-Montero J, Cardozo C, Peman J, Montejo M, Fortún J, Almirante B, Castro C, Rodríguez-Baño J, Aguado JM, Martínez JA, Carratalà J, Soriano A, Garcia-Vidal C.

    Early Stepdown From Echinocandin to Fluconazole Treatment in Candidemia: A Post Hoc Analysis of Three Cohort Studies.

    Open forum infectious diseases . 8(6): . Nº de citas: 2

    [doi:10.1093/ofid/ofab250]